Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Sensitivity of Pharmacokinetics to Differences in Aerodynamic Particle Size Distribution (NCT01966692)University of Florida2016-11-01
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer (NCT02705196)Lokon Pharma AB2016-11-01
First-in-Human Single and Multiple Dose of EB8018 (NCT02998190)Enterome2016-11-01
Clinical Trial of AVL-3288 in Schizophrenia Patients (NCT02978599)New York State Psychiatric Institute2016-11-01
A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application (NCT02980315)The Second Hospital of Nanjing Medical University2016-11-01
Thermal Imaging for Evaluation of the Cervix (NCT02908607)Meir Medical Center2016-11-01
Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (NCT02964455)Sun Yat-sen University2016-11-01
Tissue Stresses of Cancer (Force Horizon 2020) (NCT03238144)Guy's and St Thomas' NHS Foundation Trust2016-11-01
Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis (NCT03037788)Dr. August Wolff GmbH & Co. KG Arzneimittel2016-11-01
Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis (NCT02999776)Pantec Biosolutions AG2016-11-01
Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia (NCT02654860)Sintetica SA2016-11-01
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis (NCT02475772)Clemens Tempfer2016-11-01
Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee (NCT02965495)Yooyoung Pharmaceutical Co., Ltd.2016-11-01
An Evaluation of Omega-3 Fatty Acid (NCT03017651)Société des Produits Nestlé (SPN)2016-11-01
A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects (NCT02957474)Celgene2016-11-01
The Stanford Parkinson's Disease Plasma Study (NCT02968433)Stanford University2016-11-01
Trial of TRC105 and Sorafenib in Patients With HCC (NCT02560779)Tracon Pharmaceuticals Inc.2016-11-01
Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia (NCT02914977)Tara Lin2016-11-01
Neuroimaging GABA Physiology in Fragile X Syndrome (NCT04308954)Stanford University2016-11-01
A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects (NCT02986529)Shanghai Greenvalley Pharmaceutical Co., Ltd.2016-11-01
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia (NCT03013998)Beat AML, LLC2016-11-01
A Study of LY3185643 and rGlucagon in Healthy Participants (NCT02951780)Eli Lilly and Company2016-11-01
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer (NCT02922764)Inspirna, Inc.2016-11-01
MRA With Feraheme in HHT (NCT02977637)University of California, Los Angeles2016-11-01
Efficacy of Intrathecal Versus Intravenous Dexmedetomidine for Prevention of Post Spinal Anesthesia Shivering (NCT02965586)Assiut University2016-11-01
Smartphone Technology: Young Adult Drinking (NCT02963818)University of Florida2016-11-01
Treatment of Recurrent Clostridium Difficile Infection With RBX7455 (NCT02981316)Mayo Clinic2016-11-01
Phase I, KM-819 in Healthy Subjects for Parkinson's Disease (NCT03022799)Kainos Medicine Inc.2016-11-01
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement (NCT02957643)Hippocration General Hospital2016-11-01
L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (NCT02834403)The Methodist Hospital Research Institute2016-11-01
Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients. (NCT02981576)University of Jordan2016-11-01
Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment (NCT03053219)Hangzhou ACEA Pharmaceutical Research Co., Ltd.2016-11-01
Phase 1 Study of GSK2315698 in Healthy Japanese Subjects (NCT02953808)GlaxoSmithKline2016-11-01
Ibrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02635074)Steven E. Coutre2016-11-01
Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers (NCT02963324)University Hospital, Basel, Switzerland2016-11-01
Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected Adults (NCT02960581)International AIDS Vaccine Initiative2016-11-01
A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects (NCT03056326)Chiesi Farmaceutici S.p.A.2016-11-01
Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts (NCT02967666)National University Hospital, Singapore2016-11-01
Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies (NCT02906670)Symphogen A/S2016-11-01
Single Versus Multiple Visits Endodontic Treatment (NCT02947763)Cairo University2016-11-01
Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers (NCT02786082)Lee's Pharmaceutical Limited2016-11-01
MRI Compatible and Long-term LFP Recordable Deep Brain Stimulation on PD Patients (NCT02937727)Beijing Pins Medical Co., Ltd2016-11-01
A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers (NCT02953132)Tanabe Pharma Corporation2016-11-01
Nivolumab in Relapsed Pediatric Solid Tumors (NCT02901145)Hadassah Medical Organization2016-11-01
A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects (NCT03265106)Shenzhen BinDeBio Ltd.2016-11-01
Open-Label Crossover Study Comparing CTP-543 to Jakafi® (NCT02960945)Concert Pharmaceuticals2016-11-01
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents (NCT02964377)Craig McDonald, MD2016-11-01
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers (NCT02972255)Hoffmann-La Roche2016-10-31
A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors (NCT02923349)Incyte Biosciences International Sàrl2016-10-31
Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally (NCT02957929)Basilea Pharmaceutica2016-10-31
A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML) (NCT02892318)Hoffmann-La Roche2016-10-31
TAS-OX for Refractory Metastatic Colon Cancer (NCT02848079)Yale University2016-10-31
The Effect of Paravertebral Block With Dexamethasone on Intraoperative and Postoperative Analgesia in Children Undergoing Surgery for Coarctation of Aorta (NCT03074773)Cairo University2016-10-30
Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects (NCT02952547)Daewoong Pharmaceutical Co. LTD.2016-10-30
Comparison Between Skin Graft Versus Skin Graft and Stem Cell Application (NCT04219657)King Edward Medical University2016-10-29
An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration (NCT02848313)Stealth BioTherapeutics Inc.2016-10-28
Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera® (NCT03061838)Biointegrator LLC2016-10-27
Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids) (NCT02889848)Advance Biofactures Corporation2016-10-27
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia (NCT02933320)Cancer Research UK2016-10-27
Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers (NCT02912247)Innovent Biologics (Suzhou) Co. Ltd.2016-10-27
Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment (NCT03289208)Shionogi2016-10-27
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle (NCT02817464)Teva Branded Pharmaceutical Products R&D, Inc.2016-10-26
Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis (NCT02805855)Jacob L. Sellon, M.D.2016-10-26
To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment (NCT02942810)Wockhardt2016-10-25
A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM (NCT02766699)Engeneic Pty Limited2016-10-25
A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects (NCT02922933)Syndax Pharmaceuticals2016-10-25
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors (NCT02897375)Emory University2016-10-24
BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study (NCT02936492)Bayer2016-10-24
Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study (NCT02563769)Temple University2016-10-24
A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer (NCT02789345)Eli Lilly and Company2016-10-24
Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer (NCT02800889)CTI BioPharma2016-10-24
A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects (NCT03273192)Cinnagen2016-10-22
A Study of SENS 401 in Healthy Subjects (NCT03071003)Simbec Research2016-10-21
Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali (NCT02942277)National Institute of Allergy and Infectious Diseases (NIAID)2016-10-21
A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents (NCT02745769)Eli Lilly and Company2016-10-21
A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors (NCT02829723)Novartis Pharmaceuticals2016-10-21
Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies (NCT02913131)Rahul Aggarwal2016-10-20
Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours (NCT02855203)Peter MacCallum Cancer Centre, Australia2016-10-20
A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors (NCT02705963)Novartis Pharmaceuticals2016-10-20
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. (NCT02936102)Novartis Pharmaceuticals2016-10-20
First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors (NCT02937116)Innovent Biologics (Suzhou) Co. Ltd.2016-10-19
A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus (NCT02938572)Novo Nordisk A/S2016-10-19
This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects (NCT03102567)Lakefront Biotherapeutics NV2016-10-18
A Study of IMR-687 in Healthy Adult Volunteers (NCT02998450)Cardurion Pharmaceuticals, Inc.2016-10-18
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis (NCT02601885)AbbVie2016-10-18
A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate (NCT02927145)University of Oxford2016-10-17
A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder (NCT02902601)Janssen Research & Development, LLC2016-10-17
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma (NCT02549833)Jennie Taylor2016-10-17
Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma (NCT02867618)Columbia University2016-10-16
Phase 1 Study of Mesothelin-ADC (NCT02884726)Bristol-Myers Squibb2016-10-14
A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma (NCT02773030)Celgene2016-10-14
ZIKA Vaccine in Naive Subjects (NCT02952833)National Institute of Allergy and Infectious Diseases (NIAID)2016-10-14
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus (NCT02933853)Novo Nordisk A/S2016-10-14
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids (NCT03197623)Nancy E. Lane, MD2016-10-14
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat (NCT02890069)Novartis Pharmaceuticals2016-10-14
Study of a Steroid Delivery System for Pain Relief Treatment in Patients With Knee Osteoarthritis (NCT02873273)Mark Figgie2016-10-14
Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma (NCT02935309)H. Lee Moffitt Cancer Center and Research Institute2016-10-14
Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB (NCT04520022)Gangnam Severance Hospital2016-10-13
Pilot Study of the Safety/Efficacy of Combination Checkpoint Blockade + External Beam Radiotherapy in Stage IV Melanoma (NCT02659540)Ludwig Institute for Cancer Research2016-10-13
A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors (NCT03042910)Pfizer2016-10-13
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.